Oelschlager Kristen M exercised Options for 4,152 Castle Biosciences shares at $3.38 per share and sold 4,152 shares in transactions priced from $33.36 to $34.02. The activity leaves her with 13,356 shares and 12,458 derivative securities, updating investors on her reported holdings.
Key Highlights
- The Castle Biosciences chief operating officer’s share sales occurred across two transactions on 1 September 2026.
- Oelschlager Kristen M held 13,356 Castle Biosciences shares after the sales.
- Her reported ownership after the derivative-security transaction was 12,458 derivative securities.
Oelschlager Kristen M exercised options for 4,152 Castle Biosciences (NASDAQ: CSTL) shares at $3.38 per share on 1 September 2026, then sold 4,152 shares across two transactions.
Option Exercise and Share Sales
Oelschlager Kristen M serves as chief operating officer of Castle Biosciences. Following the option exercise, her reported share ownership was 17,508 shares. The subsequent sales were completed at prices ranging from $33.36 to $34.02 per share. After those transactions, her reported ownership stood at 13,356 shares. The option activity also covered 4,152 derivative securities of Castle Biosciences.
FAQs
Q: What did Oelschlager Kristen M do in the Castle Biosciences insider transaction?
A: Oelschlager Kristen M exercised options for 4,152 Castle Biosciences shares at $3.38 per share and sold 4,152 shares across two transactions.
Q: What were the Castle Biosciences share sale prices?
A: The Castle Biosciences shares were sold in two transactions on 1 September 2026 at prices ranging from $33.36 to $34.02 per share.
Q: How many Castle Biosciences shares did Oelschlager Kristen M own afterward?
A: Following the two sales transactions on 1 September 2026, Oelschlager Kristen M owned 13,356 Castle Biosciences shares. This was the reported share ownership after the sales.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.